Department of Pediatrics, Gangnam Severance Hospital, Seoul, Korea.
Institute of Allergy, Department of Biomedical Science, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.
J Investig Allergol Clin Immunol. 2024 Jul 29;34(4):246-256. doi: 10.18176/jiaci.0918. Epub 2023 Jun 1.
Respiratory microbiome studies have improved our understanding of the various phenotypes and endotypes in heterogeneous asthma. However, the relationship between the respiratory microbiome and clinical phenotypes in children with asthma remains unclear. We aimed to identify microbiome-driven clusters reflecting the clinical features of asthma and their dominant microbiotas in children with asthma.
Induced sputum was collected from children with asthma, and microbiome profiles were generated via sequencing of the V3-V4 region of the 16S rRNA gene. Cluster analysis was performed using the partitioning around medoid clustering method. The dominant microbiota in each cluster was determined using linear discriminant effect size analysis. Each cluster was analyzed to identify associations between the dominant microbiota, clinical phenotype, and inflammatory cytokines.
We evaluated 83 children diagnosed with asthma. Among 4 clusters reflecting the clinical characteristics of asthma, cluster 1, dominated by the genera Haemophilus and Neisseria, demonstrated lower postbronchodilator (BD) forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) than the other clusters and more mixed granulocytic asthma. Neisseria correlated negatively with pre-BD and post-BD FEV1/FVC. Haemophilus and Neisseria correlated positively with programmed death-ligand (PD-L) 1.
To our knowledge, this study is the first to analyze the relationship between an unbiased microbiome-driven cluster and clinical phenotype in children with asthma. The cluster dominated by Haemophilus and Neisseria was characterized by fixed airflow obstruction and mixed granulocytic asthma, which correlated with PD-L1 levels. Thus, unbiased microbiome-driven clustering can help identify new asthma phenotypes related to endotypes in childhood asthma.
呼吸微生物组研究提高了我们对异质性哮喘中各种表型和内型的认识。然而,哮喘儿童的呼吸微生物组与临床表型之间的关系尚不清楚。我们旨在确定反映哮喘临床特征的微生物组驱动聚类及其在哮喘儿童中的主要微生物群。
从哮喘儿童中采集诱导痰,并通过测序 16S rRNA 基因的 V3-V4 区生成微生物组谱。使用中值聚类方法进行聚类分析。使用线性判别效应大小分析确定每个聚类中的主要微生物群。分析每个聚类,以确定主要微生物群、临床表型和炎症细胞因子之间的关联。
我们评估了 83 名被诊断为哮喘的儿童。在反映哮喘临床特征的 4 个聚类中,以属嗜血杆菌和奈瑟菌为主的聚类 1 显示支气管扩张后(BD)用力呼气 1 秒量(FEV1)/用力肺活量(FVC)低于其他聚类,且更混合粒细胞性哮喘。奈瑟菌与 BD 前和 BD 后 FEV1/FVC 呈负相关。嗜血杆菌和奈瑟菌与程序性死亡配体(PD-L)1 呈正相关。
据我们所知,这项研究是首次分析无偏倚微生物组驱动聚类与哮喘儿童临床表型之间的关系。以嗜血杆菌和奈瑟菌为主的聚类表现为固定气流阻塞和混合粒细胞性哮喘,与 PD-L1 水平相关。因此,无偏倚的微生物组驱动聚类可以帮助确定与儿童哮喘内型相关的新哮喘表型。